Clinical safety and efficacy of bispecific antibody in the treatment of solid tumors: A protocol for a systematic review

Seyed Aria Nejadghaderi; Maryam Balibegloo; Amene Saghazadeh; Nima Rezaei

doi:10.1371/journal.pone.0271506

Loading metrics

Open Access

Clinical safety and efficacy of bispecific antibody in the treatment of solid tumors: A protocol for a systematic review

Seyed Aria Nejadghaderi ,

Contributed equally to this work with: Seyed Aria Nejadghaderi, Maryam Balibegloo

Roles Conceptualization, Investigation, Methodology, Writing – original draft, Writing – review & editing

Affiliations Systematic Review and Meta-Analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran, Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran

https://orcid.org/0000-0002-8692-9720

⨯
Maryam Balibegloo ,

Contributed equally to this work with: Seyed Aria Nejadghaderi, Maryam Balibegloo

Roles Conceptualization, Investigation, Methodology, Writing – original draft, Writing – review & editing

Affiliations Systematic Review and Meta-Analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran, Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran, Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran

https://orcid.org/0000-0002-0863-7255

⨯
Amene Saghazadeh,

Roles Methodology, Supervision, Writing – review & editing

Affiliations Systematic Review and Meta-Analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran, Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences (TUMS), Tehran, Iran
⨯
Nima Rezaei

Roles Project administration, Supervision, Writing – review & editing

* E-mail: nimarezaei.usern@gmail.com, rezaei_nima@tums.ac.ir

Affiliations Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran, Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences (TUMS), Tehran, Iran, Department of Immunology, School of Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran

https://orcid.org/0000-0002-3836-1827

⨯

Clinical safety and efficacy of bispecific antibody in the treatment of solid tumors: A protocol for a systematic review

Seyed Aria Nejadghaderi,
Maryam Balibegloo,
Amene Saghazadeh,
Nima Rezaei

Published: July 18, 2022
https://doi.org/10.1371/journal.pone.0271506

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Cancer immunotherapy
Is the Subject Area "Cancer immunotherapy" applicable to this article?

Thanks for your feedback.
Database searching
Is the Subject Area "Database searching" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Colorectal cancer
Is the Subject Area "Colorectal cancer" applicable to this article?

Thanks for your feedback.
Lung and intrathoracic tumors
Is the Subject Area "Lung and intrathoracic tumors" applicable to this article?

Thanks for your feedback.
Systematic reviews
Is the Subject Area "Systematic reviews" applicable to this article?

Thanks for your feedback.
Metaanalysis
Is the Subject Area "Metaanalysis" applicable to this article?

Thanks for your feedback.